Therapies

Tau-Targeting Alzheimer's Drug from AC Immune, Roche Fails in Phase 2

2 monthes ago   |   By Xconomy

An Alzheimer's disease drug from partners AC Immune and Roche has failed a mid-stage clinical trial, adding another compound to the list of experimental therapies that have fallen short of demonstrating that they can treat the neurodegenerative disorder. The drug, semorinemab, was tested in patients with early Alzheimer's disease. It did not achieve the Phase 2 study's main goal of beating a placebo in slowing decline according to a dementia scale, AC Immune reported Wednesday. The company added that the drug also failed to beat a placebo in secondary goals of showing improvement in...
Read more ...

 

Roche, AC Immune's tau-blocking drug flops in Alzheimer's as biotech's shares halved

Roche, AC Immune's tau-blocking drug flops in Alzheimer's as biotech's shares halved

2 monthes ago   |   By Fierce Biotech

Roche, AC Immune's tau-blocking drug flops in Alzheimer's as biotech's shares halved badams
Wed, 09/23/2020 - 08:37
Read more ...

 


Search by Tags

   Therapies      Clinical      Drugs      Drug      Immunity      Europe      Europe blog main      Europe top stories      Indiana blog main      National blog main      National top stories      AC Immune      Alzheimer's disease      Andrea Pfeifer      Biotech      Clinical trials      Genentech      Janssen Pharmaceuticals      Johnson & Johnson      Life Sciences      Marc Goodman      Roche      Semorinemab      SVB Leerink      BioTech  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Fortune: If we don't vaccinate the world quickly, all our COVID efforts will...

Fortune: If we don't vaccinate the world quickly, all our COVID efforts will be a waste

GreenLight CEO, Andrey Zarur, writes for Fortune about vaccine rollout for Covid-19. Credit: ALEX EDELMAN-GETTY IMAGES GreenLight CEO, Andrey Zarur, wrote an opinion piece for... Read more ...

Fortune: If we don't vaccinate the world quickly, all our COVID efforts will...

Fortune: If we don't vaccinate the world quickly, all our COVID efforts will be a waste

GreenLight CEO, Andrey Zarur, writes for Fortune about vaccine rollout for Covid-19. Credit: ALEX EDELMAN-GETTY IMAGES GreenLight CEO, Andrey Zarur, wrote an opinion piece for... Read more ...

IAmScience Toshi Ezashi

IAmScience Toshi Ezashi

By Lauren Hines | Bond LSC Despite his quiet demeanor, Toshi Ezashi leaves an impression on those who meet him in the halls of Bond LSC through his quiet intensity and constant... Read more ...

Connecting the World Through the Cloud

Connecting the World Through the Cloud

Maria Lusardi-Claire, an undergraduate student in the Mendoza lab, uses the cloud, a program apart of CyVerse. | photo by Becca Wolf, Bond LSC By Becca Wolf | Bond LSC Clouds... Read more ...

90 Years of Neutrino Science

90 Years of Neutrino Science

A collection of images from past, present, and pending neutrino science experiments, including: Daya Bay, DUNE at LBNF, the Homestake experiment, IceCube, KamLAND, ProtoDUNE... Read more ...

Volunteer Involvement with Biotech Professional Organizations | SoCal PDA

Volunteer Involvement with Biotech Professional Organizations | SoCal PDA

Written By: Leah Bonugli, Marketing Specialist, PSC Biotech PSC Biotech® takes great pride in the volunteer involvement of our staff with the local chapters of our biotech... Read more ...

Cover Image, Volume 89, Issue 1

Cover Image, Volume 89, Issue 1

Reverse Cover: © Science Photo Library RF/Getty Images Read more ...

Prometheus Biosciences: Associate Director, Computational Biology

Prometheus Biosciences: About Prometheus Biosciences, Inc. Prometheus Biosciences, Inc. is a privately held biotechnology company pioneering a precision medicine approach... Read more ...

Regional registration of whole slide image stacks containing major...

High resolution 2D whole slide imaging provides rich information about the tissue structure. This information can be a lot richer if these 2D images can be stacked into a 3D... Read more ...

Characterization of novel neutralizing mouse monoclonal antibody JM1-24-3...

Abstract Background MUC18 is a glycoprotein highly expressed on the surface of melanoma and other cancers which promotes tumor progression and metastasis. However, its... Read more ...